Showing 1 - 10 of 782
Medical cost-effectiveness analysis (CEA) is perhaps the most widely applied tool to guide policy decisions concerning the use of health care resources. This chapter first reviews the rationale for and common practice of medical cost-effectiveness analysis. It seeks to place CEA within a...
Persistent link: https://www.econbiz.de/10014025581
Despite spending far more on medical care, Americans live shorter lives than the citizens of other high-income countries. The situation has been getting worse for at least three decades. This paper describes the main scientific methods for guiding the allocation of resources to health -...
Persistent link: https://www.econbiz.de/10010361480
OBJECTIVE: The objective of this study was to assess the cost-efficacy of atorvastatin, simvastatin, lovastatin, fluvastatin, pravastatin and cholestyramine to reduce LDL-cholesterol levels and the cost per patient to achieve National Cholesterol Education Program (Adult Treatment Panel-III)...
Persistent link: https://www.econbiz.de/10014055621
Markov-based and discrete event simulation models are widely used in health economic analysis to estimate the long term effects of treatment on clinical and economic outcomes. However, none of them simultaneously integrate patients' economic resources and their medical decision making in the...
Persistent link: https://www.econbiz.de/10012982762
Futurists, investors, and health-law programs all try to catch a glimpse of the future of healthcare. Lucky for you, you've got me. I'm from the future. I've travelled back in time from the year 2045. And I am here to tell you, the future of healthcare reform is awesome
Persistent link: https://www.econbiz.de/10013015651
The creation of tax-free health savings accounts presents a new opportunity to reduce the distortions created by federal tax preferences for health-related expenditures, and ultimately help eliminate those distortions. This paper proposes changes to current law that would allow most workers to...
Persistent link: https://www.econbiz.de/10014052242
This study examines the relationship between pharmaceutical R&D and health care expenditures, distinguishing between the short- and long-run impacts. To measure these relationships quantitatively, we focus on patents as a key factor driving the costs of pharmaceuticals, and develop a structured...
Persistent link: https://www.econbiz.de/10014209235
Germany’s healthcare system is praised as one of the best in the world. In this article, we review Germany’s health system by critically analysing its structure, funding, resource allocation, provider payments, efficiency, health outcomes, and access. Whilst health provision and access are...
Persistent link: https://www.econbiz.de/10014085051
Persistent link: https://www.econbiz.de/10011318497
Persistent link: https://www.econbiz.de/10012795990